ResMed Inc.  

(Public, NYSE:RMD)   Watch this stock  
Find more results for resmed
60.52
-3.56 (-5.56%)
Jun 24 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range 60.49 - 62.59
52 week 48.99 - 62.59
Open 62.59
Vol / Avg. 1.49M/725,195.00
Mkt cap 8.74B
P/E 24.73
Div/yield 0.30/1.98
EPS 2.45
Shares 140.41M
Beta 0.66
Inst. own 62%
Jul 28, 2016
Q4 2016 ResMed Inc Earnings Release (Estimated) - 4:00PM EDT - Add to calendar
Jun 14, 2016
ResMed Inc at William Blair Growth Stock Conference - Webcast
Apr 26, 2016
Q3 2016 ResMed Inc Earnings Call
Apr 26, 2016
Q3 2016 ResMed Inc Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '16) 2015
Net profit margin 19.49% 21.02%
Operating margin 22.98% 24.38%
EBITD margin - 28.73%
Return on average assets 15.15% 15.53%
Return on average equity 22.19% 21.10%
Employees 4,340 -
CDP Score - -

Address

9001 Spectrum Center Blvd
SAN DIEGO, CA 92123-1438
United States - Map
+1-858-7462400 (Phone)
+1-858-8365501 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

ResMed Inc. is a holding company. The Company, through its subsidiaries, designs, manufactures and markets equipment for the diagnosis and treatment of sleep-disordered breathing and other respiratory disorders, including obstructive sleep apnea. The Company develops a range of products for sleep-disordered breathing and other respiratory disorders, including airdevices, informatics solutions, diagnostic products, mask systems, headgear and other accessories. The Company owns interest in Inova Labs Inc., a medical device company specializing in the development and commercialization of oxygen therapy products. The Company holds interest in Brightree LLC, a provider of business management and clinical software applications for the post-acute care industry. The Company's manufacturing operations are located in Australia, Singapore, France, Germany, Malaysia and the United States.

Officers and directors

Robert D. Douglas President, Chief Operating Officer
Age: 55
Bio & Compensation  - Reuters
Michael J. Farrell Chief Executive Officer, Director
Age: 43
Bio & Compensation  - Reuters
Brett A. Sandercock Chief Financial Officer
Age: 48
Bio & Compensation  - Reuters
Don Darkin President – innovation & operations
Age: 62
Bio & Compensation  - Reuters
Jim Hollingshead Ph.D. President - Americas
Age: 52
Bio & Compensation  - Reuters
Anne Reiser President – Europe & Asia Pacific
Age: 54
Bio & Compensation  - Reuters
David Brian Pendarvis Chief Administrative Officer, Global General Counsel, Company Secretary
Age: 56
Bio & Compensation  - Reuters
Agnes Lee Senior Director - Investor Relations
Bio & Compensation  - Reuters
Peter C. Farrell Ph.D. Non-Executive Chairman of the Board
Age: 73
Bio & Compensation  - Reuters
Ronald R. Taylor Lead Independent Director
Age: 67
Bio & Compensation  - Reuters